Scott R. Walker's scientific contributions
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publication (1)
The science of psychedelics is an intriguing, multi-disciplinary field that has recently been the subject of heightened public interest. This has mainly resulted from publicity associated with a number of high-profile investigations into psychedelic-assisted therapy for a range of difficult-to-treat mental health conditions. With many psychedelic s...
Citations
... 3,4-Methylenedioxymethamphetamine (MDMA), better known by its street name 'ecstasy', is a popular recreational drug with a long and interesting history [1][2][3][4][5] (see also the primer in this special issue). [6] The best-known member of a sub-class of psychedelic drugs known as the entactogens, MDMA has prosocial, mood-elevating, anxiolytic and fear-extinguishing behavioural effects that make it an attractive adjunct to psychotherapy. [7][8][9] Indeed, MAPS, the Multidisciplinary Association for Psychedelic Studies, have completed two successful Phase III clinical trials of MDMA-assisted psychotherapy for post-traumatic stress disorder (PTSD) in which MDMA was found to be highly efficacious. ...
![[object Object]](https://i1.rgstatic.net/ii/profile.image/276934849253382-1443037822033_Q64/Matthew-Piggott.jpg)
